An RF engineer explains why sensor physics and analog design, not software, determine whether wearable trial data can be trusted.
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Why Life Science Tech Pilots Fail After The Demo — And How To Avoid It
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
- How Versiti Turns Data Into A Lifeline For Rare Blood Patients
- What Is Shadow AI, And How Does It Impact Clinical Trial Tech?
- Will AI And Agile Project Management Help Advance RBM?
- Building A Clinical Trial Tech Stack That Actually Works
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Clinical Trial Logistics: Meeting Unique Participant Needs
Uncover why delivering a comprehensive service entails establishing a robust global network equipped with the expertise, resources, and adaptability to address diverse participant needs worldwide.
-
Solving Key eCOA Challenges Through Digital Trials—Proof Points!
Medable has reached some important milestones and shares them in its end-of-year report. Check it out to see what game-changing results they've brought to their customers.
-
A Leading Academic Medical Center Monitors Newly Diagnosed Myeloma Patients
Learn how eCOA helped to motivate patients and increased engagement around experiences outside of the clinical setting, which otherwise may have gone unmentioned.
-
RBQM For Decentralized Trials: Two Key Areas Of Focus To Reduce Your Risk
This article takes a more in-depth look at Sections 5.0.5: ‘Risk Communication’ and 5.0.6: ‘Risk Review.’ in ICH-GCP E6 R2 to show how the implementation of RBQM can reduce issues and achieve holistic trial oversight in today’s complex decentralized trials.
-
Reliable Methods For Examining Long-Term Wearables In Gait & Sway
Review this evaluation framework for wear duration when confirming if wearable sensor-based methods for capturing gait and balance impairment in the free-living environment are fit for purpose.
-
FDA Releases Updated Draft Guidance On Decentralized Clinical Trials
Take a closer look at the FDA's draft guidance on designing and implementing DCTs, notably remote trial visits, the use of digital health technologies, institutional review board oversight, and more.
-
The Transformative Impact Of EDC Systems In 2025
The shift towards decentralized and hybrid trials underscores the significance of EDC in expanding geographic reach, fostering diversity in participant populations, and reduce participant burden.
-
Removing Translation Bottlenecks With AI
See how an AI-enabled approach eliminated the manual, time-consuming translation bottlenecks that often delay clinical trial launches.
-
Navigating eCOA Licensing And Localization In Clinical Trials
eCOA has been key in trials for 20 years, but issues like licensing, localization, and execution quality still challenge sponsors.
-
When To Use Wearables In A Clinical Trial And How to Get Started
Wearables work best when they close real measurement gaps — from irregular symptoms to mobility and sleep. In a unified data environment, they deliver richer insights without added complexity.
- Why Trustworthy Clinical Trial Data Starts As Analog, Not Digital
- Why Clinical Trial Coordinators Are Still The Human API
- Designing eCOA Technology Patients Can Actually Use
- Clinical Trial Technology Doesn't Fail – It Fails At The Handoff
- Inside Versiti's Data Strategy: Building AI-Ready Research Systems
RECENT NEWSLETTERS
- 07.23.26 -- AI, Data Costs, And The Real Barriers To Trial Execution
- 07.16.26 -- Why Clinical Trial Sites Are Drowning In Tech Chaos
- 07.09.26 -- AI Governance, Real-Time Trials, And Hidden Risks to Watch
- 07.03.26 -- Best Of June: AI, Data, And What's Fixing Trial Execution
- 07.02.26 -- How AI And Real-Time Tech Are Changing Trial Execution